Skip to main content
SpringerLink
Log in

The US Preventive Services Task Force has recommended that patients and clinicians consider risk factors before deciding to use aspirin

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Agency for Healthcare Research & Quality.Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms. Media Release: 16 Mar 2009. Available from: URL: http://www.ahrq.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The US Preventive Services Task Force has recommended that patients and clinicians consider risk factors before deciding to use aspirin. Pharmacoecon. Outcomes News 575, 2 (2009). https://doi.org/10.2165/00151234-200905750-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905750-00003

Keywords

Search

Navigation